Capsule Endoscopy Market Size, Share, Growth Analysis, By Product (Oesophageal Capsule, Small Bowel Capsule), By Application (Obscure Gastrointestinal Bleeding (OGIB), Crohn’S Disease), By End-User (Hospitals, Diagnostic Laboratories), By Region - Industry Forecast 2025-2032

Global Capsule Endoscopy Market size was valued at USD 799.36 million in 2022 and is poised to grow from USD 898.48 million in 2023 to USD 2288.97 million by 2031, growing at a CAGR of 12.4% during the forecast period (2024-2031).

Due to the increasing demand for capsule-based endoscopes and endoscopic systems for various screening and diagnostic procedures, there is intense competition among the existing providers. The rivalry is also growing as a result of technological developments made in the field of endoscopy by important players. Prominent market players are taking steps to grow their R&D in the field of capsule-based endoscopic technologies, as well as strategic alliances with other market competitors through mergers and acquisitions, product launches, collaborations, and other activities. IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd., RF System lab, and CapsoVision are a few of the key players in the capsule endoscopy market. 'Olympus Corporation ', 'Chongqing Jinshan Science & Technology Co. Ltd. ', 'IntroMedic Co. Ltd. ', 'CapsoVision Inc. ', 'Ankon Medical ', 'RF System lab ', 'AccuRead Endoscopy Inc. ', 'Northside Gastroenterology Endoscopy Center LLC ', 'Interscope Inc. ', 'Fujifilm Holding Corporation ', 'Cook Medical ', 'ConMed Corporation ', 'The Guidant Group ', 'RF Co. ', 'CapsoCam Plus ', 'Check-Cap Ltd. ', 'Smart Medical Systems Ltd. ', 'SynMed ', 'Medimetrics ', 'Jinshan Science & Technology '

The range of applications for capsule endoscopy systems, including those for colon disease, small bowel disease, and esophageal illness, has increased due to technological developments. Technological advancements have enhanced the traditional endoscopy's diagnostic, monitoring, and viewing capabilities. New varieties of capsule endoscopes, including those for the small intestine, colon, and oesophagus, have been developed as a result of advanced technologies. Product manufacturers are also developing user-friendly and high-resolution cameras with a 360-degree panoramic view. Endoscopy now has a high level of accuracy, safety, and precision thanks to advancements that would have been difficult to attain only a few years ago. The video scope and the capsule endoscope have replaced the fibreoptic endoscope (fiberscope) period recently. Also, in November, 2021, PillCam Small Bowel 3 system for remote endoscopy procedures. With the use of Amazon logistics and Medtronic's PillCam technology, the PillCam SB3 @HOME programme aims to give patients access to rapid, reliable results from the convenience of their own homes. The telehealth option PillCam SB3 @HOME allows for direct vision and monitoring of the small bowel. It can assist in identifying lesions that are missed by upper and lower endoscopy and may: indicate Crohn's disease, find hidden bleeding, or reveal the causes of iron deficiency anaemia (IDA).

Increase in Gastrointestinal Disorders Worldwide to Drive Global Capsule Endoscopy Market Growth: Due to a variety of environmental factors as well as a shift in people's overall lifestyles, medical illnesses such gastrointestinal disorders, inflammatory bowel diseases, and colorectal cancer have developed dramatically in recent years. Globally, the number of cases of colorectal cancer is rising. The second most prevalent disease to cause death and the third most frequently diagnosed cancer is colorectal cancer. The death rate linked to colorectal cancer can be significantly decreased by screening and increased awareness. Additionally, GI problems like CRC, inflammatory bowel disease, and appendicitis are more likely to develop as people age; for this reason, screening is crucial to prevent complications and further development of GI disorders. According to the National Colorectal Round Table, screening at age of 50 can prevent 230,000 deaths from colorectal cancer. The need for capsule endoscopy is predicted to rise significantly in the upcoming years due to the rise in these medical disorders. The standard procedure for detecting colorectal cancer is a colonoscopy. However, capsule endoscopy is being used more frequently as a result of the limitations of colonoscopy and the rising need for minimally invasive procedures. A non-invasive wireless diagnostic technique called capsule endoscopy gives doctors a thorough view of the small intestine. The use of technology has completely changed how small intestine problems like cancer, inflammatory bowel disease, celiac disease, and mysterious gastrointestinal bleeding are diagnosed and treated.

North America region is expected to hold the largest market share in the global capsule endoscopy market